{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Clinical trial design", "Non-alcoholic steatohepatitis", "Randomised controlled trial", "Traditional Chinese medicine"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37208742", "DateRevised": {"Year": "2023", "Month": "05", "Day": "22"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "05", "Day": "19"}], "Language": ["eng"], "ELocationID": ["58", "10.1186/s13020-023-00761-5"], "Journal": {"ISSN": "1749-8546", "JournalIssue": {"Volume": "18", "Issue": "1", "PubDate": {"Year": "2023", "Month": "May", "Day": "19"}}, "Title": "Chinese medicine", "ISOAbbreviation": "Chin Med"}, "ArticleTitle": "Systematic analysis of randomised controlled trials of Chinese herb medicine for non-alcoholic steatohepatitis (NASH): implications for future drug development and trial design.", "Pagination": {"StartPage": "58", "MedlinePgn": "58"}, "Abstract": {"AbstractText": ["Non-alcoholic steatohepatitis (NASH) is a liver disease currently lacking an approved therapy, resulting in significant clinical demand. Traditional Chinese medicines (TCMs) have been commonly used to manage NASH. This study aimed to systematically analyse the randomised controlled trials (RCTs) using TCMs for NASH management.", "A systematic literature review was performed by following PRISMA guidelines 2020 in six electronic databases: PubMed, Web of Science, Scopus, Embase, the Cochrane Library, and China National Knowledge Infrastructure, from inception until August 2022. RCTs using TCMs for NASH were included in the analysis, irrespective of language or blinding.", "112 RCTs were included in this review, with 10,573 NASH participants. 108 RCTs were conducted in China, and 4 RCTs were in other countries. Herbal medicine decoction was the major dosage form used for treating NASH (82/112). 11 TCMs products have been approved for NASH treatment (8 in China, 2 in Iran, and 1 in Japan). Classic prescriptions, such as \"Huang Lian Jie Du decoction\", \"Yin Chen Hao decoction\", and \"Yi Guan Jian\" were used in some studies. The TCMs treatment of NASH involved the use of 199 different plants, with the top 5 herbs being Salviae Miltiorrhizae Radix Et Rhizoma, Alismatis Rhizoma, Bupleuri Radix, Poria, and Curcumae Radix. \"Salviae Miltiorrhizae Radix Et Rhizoma\u2009+\u2009Bupleuri Radix/Alismatis Rhizoma\" were the mostly common drug-pair in the herbs network analysis. Nowadays, \"Bupleuri Radix/Alismatis Rhizoma\u2009+\u2009Atractylodis Macrocephalae Rhizoma\" are increasingly applied in herbal formulas for NASH. Based on the PICOS principles, the included studies varied in terms of the population, intervention, comparator, outcomes, and study design. However, some studies reported unstandardised results and failed to report diagnostic standards, inclusion or exclusion criteria, or sufficient patient information.", "Adopting Chinese classic prescriptions or drug-pair may provide a basis for developing new drugs of NASH management. Further research is needed to refine the clinical trial design and obtain more convincing evidence for using TCMs to treat NASH."], "CopyrightInformation": "\u00a9 2023. The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Taipa, Macao, China."}], "LastName": "Chen", "ForeName": "Xianwen", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Taipa, Macao, China."}], "LastName": "Shi", "ForeName": "Junnan", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Public Health and Management, Guangzhou University of Chinese Medicine, Guangzhou, China."}], "LastName": "Lai", "ForeName": "Yunfeng", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Taipa, Macao, China."}], "LastName": "Xue", "ForeName": "Yan", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Taipa, Macao, China. carolinaung@um.edu.mo."}, {"Identifier": [], "Affiliation": "Department of Public Health and Medicinal Administration, Faculty of Health Sciences, University of Macau, Taipa, Macao, China. carolinaung@um.edu.mo."}], "LastName": "Ung", "ForeName": "Carolina Oi Lam", "Initials": "COL"}, {"Identifier": ["0000-0001-9441-106X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Taipa, Macao, China. haohu@um.edu.mo."}, {"Identifier": [], "Affiliation": "Department of Public Health and Medicinal Administration, Faculty of Health Sciences, University of Macau, Taipa, Macao, China. haohu@um.edu.mo."}], "LastName": "Hu", "ForeName": "Hao", "Initials": "H"}], "GrantList": [{"GrantID": "QRCMIRG2022-009", "Agency": "State Key Laboratory of Quality Research in Chinese Medicine, University of Macau", "Country": ""}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Chin Med", "NlmUniqueID": "101265109", "ISSNLinking": "1749-8546"}, "CoiStatement": "The authors declare that they have no competing interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Sheka AC, Adeyi O, Thompson J, Hameed B, Crawford PA, Ikramuddin S. Non-alcoholic steatohepatitis: a review. JAMA. 2020;323(12):1175\u20131183. doi: 10.1001/jama.2020.2298.", "ArticleIdList": ["10.1001/jama.2020.2298", "32207804"]}, {"Citation": "Takahashi Y, Fukusato T. Histopathology of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis. World J Gastroenterol. 2014;20(42):15539\u201315548. doi: 10.3748/wjg.v20.i42.15539.", "ArticleIdList": ["10.3748/wjg.v20.i42.15539", "PMC4229519", "25400438"]}, {"Citation": "Perumpail B, Khan M, Yoo E, Cholankeril G, Kim D, Ahmed A. Clinical epidemiology and disease burden of non-alcoholic fatty liver disease. World J Gastroenterol. 2017;23(47):8263\u20138276. doi: 10.3748/wjg.v23.i47.8263.", "ArticleIdList": ["10.3748/wjg.v23.i47.8263", "PMC5743497", "29307986"]}, {"Citation": "Estes C, Anstee QM, Arias-Loste MT, et al. Modeling nafld disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016\u20132030. J Hepatol. 2018;69(4):896\u2013904. doi: 10.1016/j.jhep.2018.05.036.", "ArticleIdList": ["10.1016/j.jhep.2018.05.036", "29886156"]}, {"Citation": "Lonardo A, Byrne CD, Caldwell SH, Cortez-Pinto H, Targher G. Global epidemiology of non-alcoholic fatty liver disease. Meta-analytic assessment of prevalence, incidence and outcomes. Hepatology. 2016;64(4):1388\u20131389. doi: 10.1002/hep.28584.", "ArticleIdList": ["10.1002/hep.28584", "27038241"]}, {"Citation": "European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64(6):1388\u2013402.", "ArticleIdList": ["27062661"]}, {"Citation": "Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328\u2013357. doi: 10.1002/hep.29367.", "ArticleIdList": ["10.1002/hep.29367", "28714183"]}, {"Citation": "O'Hara J, Finnegan A, Dhillon H, Ruiz-Casas L, Pedra G, Franks B, Morgan G, Hebditch V, J\u00f6nsson B, Mabhala M, Reic T. Cost of non-alcoholic steatohepatitis in Europe and the USA: the GAIN study. JHEP Reports. 2020;2(5):100142. doi: 10.1016/j.jhepr.2020.100142.", "ArticleIdList": ["10.1016/j.jhepr.2020.100142", "PMC7397699", "32775976"]}, {"Citation": "Tampi RP, Wong VW-S, Wong GL-H, Shu SS-T, Chan HL-Y, Fung J, et al. Modelling the economic and clinical burden of non-alcoholic steatohepatitis in East Asia: data from Hong Kong. Hepatol Res. 2020;50(9):1024\u201331.", "ArticleIdList": ["32537840"]}, {"Citation": "Singh S, Allen AM, Wang Z, et al. Fibrosis progression in non-alcoholic fatty liver vs non-alcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. Clin Gastroenterol Hepatol. 2015;13(4):643\u2013654.e9. doi: 10.1016/j.cgh.2014.04.014.", "ArticleIdList": ["10.1016/j.cgh.2014.04.014", "PMC4208976", "24768810"]}, {"Citation": "Vuppalanchi R, Noureddin M, Alkhouri N, Sanyal AJ. Therapeutic pipeline in non-alcoholic steatohepatitis. Nat Rev Gastroenterol Hepatol. 2021;18(6):373\u2013392. doi: 10.1038/s41575-020-00408-y.", "ArticleIdList": ["10.1038/s41575-020-00408-y", "33568794"]}, {"Citation": "Chen M, Xie Y, Gong S, Wang Y, Yu H, Zhou T, Huang F, Guo X, Zhang H, Huang R, Han Z. Traditional Chinese medicine in the treatment of non-alcoholic steatohepatitis. Pharmacol Res. 2021;172:105849. doi: 10.1016/j.phrs.2021.105849.", "ArticleIdList": ["10.1016/j.phrs.2021.105849", "34450307"]}, {"Citation": "Zhao CQ, Zhou Y, Ping J, Xu LM. Traditional Chinese medicine for treatment of liver diseases: progress, challenges and opportunities. J Integr Med. 2014;12(5):401\u2013408. doi: 10.1016/S2095-4964(14)60039-X.", "ArticleIdList": ["10.1016/S2095-4964(14)60039-X", "PMC7128864", "25292339"]}, {"Citation": "Liang Z, Chen X, Shi J, Hu H, Xue Y, Ung CO. Efficacy and safety of traditional Chinese medicines for non-alcoholic fatty liver disease: a systematic literature review of randomised controlled trials. Chin Med. 2021;16(1):1\u201338. doi: 10.1186/s13020-020-00422-x.", "ArticleIdList": ["10.1186/s13020-020-00422-x", "PMC7802307", "33430929"]}, {"Citation": "Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021;10(1):1\u201311. doi: 10.1186/s13643-021-01626-4.", "ArticleIdList": ["10.1186/s13643-021-01626-4", "PMC8008539", "33781348"]}, {"Citation": "Methley AM, Campbell S, Chew-Graham C, et al. PICO, PICOS and SPIDER: a comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews. BMC Health Serv Res. 2014;14(1):1\u201310. doi: 10.1186/s12913-014-0579-0.", "ArticleIdList": ["10.1186/s12913-014-0579-0", "PMC4310146", "25413154"]}, {"Citation": "National Medical Products Administration of China. Chinese medicine clinical research of new drugs guiding principles. Beijing: China Medical Science and Technology Press; 2002; p. 150\u20131 (in Chinese)."}, {"Citation": "Bastian M, Heymann S, Jacomy M. Gephi: an open source software for exploring and manipulating networks. In: Third International AAAI Conference on Weblogs and Social Media. 2009;3(1):361-362."}, {"Citation": "Shavakhi A, Torki M, Khodadoostan M, et al. Effects of cumin on non-alcoholic steatohepatitis: a double blind, randomised, controlled trial. Adv Biomed Res. 2015;4:1.", "ArticleIdList": ["PMC4627178", "26605241"]}, {"Citation": "Wong VWS, Wong GLH, Chan AWH, et al. Treatment of non-alcoholic steatohepatitis with P. hyllanthus urinaria: a randomised trial. J Gastroenterol Hepatol. 2013;28(1):57\u201362. doi: 10.1111/j.1440-1746.2012.07286.x.", "ArticleIdList": ["10.1111/j.1440-1746.2012.07286.x", "23034128"]}, {"Citation": "Rangboo V, Noroozi M, Zavoshy R, et al. The effect of artichoke leaf extract on alanine aminotransferase and aspartate aminotransferase in the patients with non-alcoholic steatohepatitis. Int J Hepatol. 2016;1:1.", "ArticleIdList": ["PMC4879230", "27293900"]}, {"Citation": "Solhi H, Ghahremani R, Kazemifar AM, et al. Silymarin in treatment of non-alcoholic steatohepatitis: a randomised clinical trial. Caspian J Intern Med. 2014;5(1):9.", "ArticleIdList": ["PMC3894463", "24490006"]}, {"Citation": "Long SS, Jang W, Dong YN, Wang WQ, Li RD. Clinical observation of self-proposed Xiaopi Huatan granules combined with Silibinin capsules in the treatment of non-alcoholic steatohepatitis with Phlegm-damp internal resistance syndrome. Guiding J Tradit Chin Med and Pharm. 2022;28(2):66\u201370."}, {"Citation": "Sun XH, Qu YZ, Zhou F, Pei C, Sun J. Clinical efficacy observation of Paizhuo Jiangmei formula and western medicine on early non-alcoholic steatohepatitis with damp-heat accumulation syndrome. Shanxi J Tradit Chin Med. 2022;38(1):23\u201326."}, {"Citation": "Tai L, Zeng YX, Fan RY, et al. Clinical effect of Quzhi Hugan decoction in treatment of non-alcoholic steatohepatitis with damp-turbidity stagnation: An analysis of 40 cases. Hunan J Tradit Chin Med. 2022;38(3):9\u201312."}, {"Citation": "Wang F, Gao XX, Wang QQ. Short-term efficacy of Huanglian Jiedu decoction and probiotics supplement in intervention of patients with non-alcoholic steatohepatitis. J Prac Hepatol. 2022;25(2):235\u2013238."}, {"Citation": "Chen WL, Liang F, Zhang YC, et al. Observe on curative effect of Yuzha Quzhi Qinggan prescription combined with glutathinone in treating non-alcoholic fatty liver disease. Chin J Integr Tradit West Med Liver Dis. 2021;31(3):216\u2013218."}, {"Citation": "He QS, Liu Y, Xu CJ. Observation of therapeutic effect of Myrrha on non-alcoholic steatohepatitis. Inner Mongolia J Tradit Chin Med. 2021;40(4):7\u201310."}, {"Citation": "Jin JJ. Clinical study on Shugan Huazhuo Tang combined with routine western medicine for non-alcoholic steatohepatitis. J New Chin Med. 2021;53(5):83\u201396."}, {"Citation": "Lei XBP, Li XY, Dai YN, et al. Clinical observation of self-made Zhiyanping granule in the treatment of 45 Cases of non-alcoholic steatohepatitis. Chin J Ethnomed Ethnopharmacy. 2021;30(5):84\u201387."}, {"Citation": "Lei YJ, Wang LL, Ye XD, Miu MJ, Zhu XQ. Clinical study on modified Chaihu Shugan Powder combined with Polyene Phosphati-dylcholine capsules for non-alcoholic steatohepatitis. J of New Chin Med. 2021;53(15):24\u201328."}, {"Citation": "Liu XJ, Wang Y, Wang N, Zhang T. Clinical study on modified Chaishao Liujunzi decoction in treatment of non-alcoholic steatohepatitis with liver stagnation and slpeen deficiency syndrome. Chin J Inf Tradit Chin Med. 2021;28(1):113\u2013117."}, {"Citation": "Wang WL, Yan FJ, Xu ML, Gao C. Clinical study on Jiangzhi Tongmai capsules combined with routine therapy for non-alcoholic steatohepatitis. J New Chin Med. 2021;53(3):73\u201376."}, {"Citation": "Zhang WH, Wu J, Li QY, et al. Efficacy of Gegen Qinlian Quzhuo decoction in treating type 2 diabetes patients with non-alcoholic fatty liver and its influence on the levels of sCD36 and ADRP.Chin J Integr Tradit West Med Liver Dis. 2021;31(9):792\u20135 (in Chinese)."}, {"Citation": "Lin XM, Chen S, Tang YQ, Yang JL. Clinical observation of 40 cases of non-alcoholic steatohepatitis with spleen deficiency, phlegm and stagnation in the treatment of liver deficiency and spleen strengthening method. China's Naturopathy. 2020;28(21):67\u201371."}, {"Citation": "Zhang XX, Liu YD, Yang ChC. Clinical study on the treatment of non-alcoholic steatohepatitis with liver-preserving and detoxifying soup combined with silymarin. J of Tradit Chin Med. 2020;48(10):47\u201351."}, {"Citation": "Zhou XM, Wang H, Wang Y. Effect of phlegm-dampness recipe on liver function and blood lipid index for patients with non-alcoholic steatosis hepatitis. J Sichuan Tradit Chin Med. 2020;38(2):105\u2013107."}, {"Citation": "Lan XM, Wu YN, Chen SD, et al. Treatment of non-alcoholic steatohepatitis by Zaozhu Yinchen recipe. Chin J Integr Tradit West Med. 2019;39(5):557\u2013580."}, {"Citation": "Sun SN, Wang Y. Clinical effects of self-made Linggui Zhugan Jiajian decoction combined with western medicine in the treatment of non-alcoholic fatty liver. Med Prac. 2019;14(9):65\u201368."}, {"Citation": "Zhou HJ, Chen G, Xie HD. Clinical evaluation of Shen Ze Shugan capsule in the treatment of non-alcoholic steatohepatitis (Damp-heat Stagnation Syndrome) Tradit Chin Drug Res and Clin Pharmacol. 2019;30(9):1133\u20131137."}, {"Citation": "Zhou YP, Yang JL, Yang P, Chen S, Guo LH, Lyu XY. Prospective cohort study of \u201cEight Zhes\u201d decoction in the treatment of non-alcoholic steatohepatitis. Chin J Mod Appl Pharm. 2019;36(17):2197\u20132201."}, {"Citation": "Zou JF. Effect of Shengjiang decoction on liver function and therapeutic effect in patients with non-alcoholic steatohepatitis of liver depression and spleen deficiency type. J Prac Tradit Chin Inter Med. 2019;33(9):57\u201359."}, {"Citation": "Cai Z, Mai JY. Clinical effects of Shenge Granules on senile non-alcoholic steatohepatitis due to Spleen Deficiency and Phlegm Turbidity. Chin Tradit Pat Med. 2018;40(9):1935\u20131938."}, {"Citation": "Chen X, Zhang JF, Sun WD, Liang RS, Lu W. Clinical study of self-made Chinese medicines in treating non-alcoholic steatohepatitis of the Pixu Tanshi type. Chin J Integr Tradit West Med Liver Dis. 2018;28(5):82\u201384."}, {"Citation": "Fan YW, Xie WP. Effect of soothing liver and strengthening spleen therapy in treating non-alcoholic steatohepatitis and analysis of changes in BMI and AC. Chin Med Modern Distance Education Chin. 2018;16(23):57\u201358."}, {"Citation": "Li HS, Ying H, He XL, He ZY. Clinical observation of Qutan Huoxue decoction for treating non-alcoholic steatohepatitis. Chin Arch Tradit Chin Med. 2018;36(7):1554\u20131556."}, {"Citation": "Lin L, Liang HQ, Zhuang HL, et al. Effect of Zaozhu Yinchen recipe on intestinal flora in treatment of non-alcoholic steatohepatitis. Chin J Integr Tradit West Med. 2018;38(6):673\u2013676."}, {"Citation": "Liu JR, Zhu XN, Wang J, Peng ZX, Peng MY. Clinical evaluation of eliminating phlegm and activating blood granule in treating non-alcoholic steatohepatitis with syndrome of phlegm and blood stasis. World Lasest Med Information. 2018;18(98):28\u201330."}, {"Citation": "Liu Y, Han XZ, Xu ML, He Y. Effect of Huanglian Jiedu decoction combined with Silybin capsule on non-alcoholic steatohepatitis with Damp-heat syndrome. J Basic Chin Med. 2018;24(9):1258\u20131261."}, {"Citation": "Mai JY, Gao YQ, Cai Z, Fang MQ. Shenge recipe in the treatment of senile non-alcoholic steatohepatitis with syndrome of phlegm turbidity due to spleen deficiency: a randomised, double-blind and placebo-controlled trial. Shanghai J TCM. 2018;52(2):44\u201348."}, {"Citation": "Wu Di, Li JX, Xie CE, et al. Observing the effect of Yinchen Linggui prescription on NASH based on liver ultrasonic attenuation parameters. Chin J Integr Trad West Med Dig. 2018;26(10):817\u201322 (in Chinese)."}, {"Citation": "Dai HY. Clinical observation of 16 cases of spleen deficiency and dampness in non-alcoholic steatohepatitis treated with Shenling Baizhu Powder. Hunan J of Tradit Chin Med. 2017;33(3):53\u201355."}, {"Citation": "He Z, Zhao Q, He XP, et al. Effects of Quzhi Yugan granule to aadiponectin and interleukin-6 in the non-alcoholic steatohepatitis (NASH) patients. Guizhou Med J. 2017;41(10):1025\u20131027."}, {"Citation": "Hu Y, Mou HJ, Chen K. Clinical effect observation of Jianpishugan and Huoxuehuatan formula on liver depression and spleen deficiency induced non-alcoholic steatohepatitis. J Nangjing Univ Tradit Chin Med. 2017;33(4):359\u2013362."}, {"Citation": "Jiang YY, Lin J, Dong PL, Wang XP. Treatment of non-alcoholic steatohepatitis by Dahuang Lidan capsule. Chin J Integr Tradit West Med. 2017;37(5):539\u2013542."}, {"Citation": "Liu D, Li P, Wang JL, Jiang ZL, Li S. Clinical study on effect of Yinchenhao decoction in treating non-alcoholic fatty liver disease and the influence of the expression of TLR-4. Chin J Integr Tradit West Med Liver Dis. 2017;27(2):80\u201382."}, {"Citation": "Liu M, Xu CJ, Li J, Wang C, Sun NN, Ding TJ. Clinical observation on the treatment of non-alcoholic steatohepatitis with hyperuricemia with the method of invigorating spleen and removing dampness, resolving phlegm and dredging collaterals. Chin J Integr Tradit West Med Liver Dis. 2017;27(4):222\u2013224."}, {"Citation": "Wang H. Curative effect of combination of traditional Chinese and Western medicine on chronic hepatitis B patients with non-alcoholic fatty liver disease. Chin J Integr Tradit West Med Liver Dis. 2017;27(3):153\u2013155."}, {"Citation": "Xin JP, Huang XF, Yang CY. Efficacy of the Tangfukang prescription on non-alcoholic steatohepatitis of the Pixu Tanshi type. Clin J Chin Med. 2017;9(4):102\u2013103."}, {"Citation": "Zhang YL, Wang XY, Ge ZX, Qi J. Clinical observation on the treatment of non-alcoholic fatty hepatitis of liver depression and spleen deficiency type with Chinese herbs for regulating the spleen, regulating the Liver, resolving phlegm and activating blood circulation. Beijing J Tradit Chin Med. 2017;36(7):636\u2013639."}, {"Citation": "Zhong BB, Tan SY. The clinical efficacy of Yinqin Qinggan Decoction in the treatment of non-alcoholic steatohepatitis and its effect on free fatty acids and TNF-\u03b1. J Sicahun Tradit Chin Med. 2017;35(9):69\u201371."}, {"Citation": "Zhou LJ, Cai LW, Li WH. Evaluation of the efficacy of combined Chinese and Western medicine in the treatment of non-alcoholic steatohepatitis. J Clin Med. 2017;4(78):15274 (in Chinese)."}, {"Citation": "Gao XF. Analysis on the efficacy and safety of Shugan Jianpi Formula in the treatment of non-alcoholic steatohepatitis. World Latest Med Inf. 2016;16(41):162\u2013163."}, {"Citation": "Qi TJ, Xu CJ, Li J, et al. Effective analysis of Shugan Jianpi Huoxue Huatan decoction in treating non-alcoholic fatty liver disease. Beijing J Tradit Chin Med. 2016;35(4):374\u2013376."}, {"Citation": "Tang JM, Liang HQ, Wang HG, Lin MT, Zhang LM, Chen SD. Efficacy of Zaozhu Yinchen recipe for treating non-alcoholic steatohepatitis and its effect on free fatty acid and TNF-\u03b1. Chin J Integr Tradit West Med. 2016;36(5):544\u2013548.", "ArticleIdList": ["27386644"]}, {"Citation": "Tian F, Zhou RJ, Zhang JN, Li MX. Clinical efficacy of Jiangzhi Hugan Tang in treatment of non-alcoholic steatohepatitis. Chin J Exper Tradit Med Formul. 2016;22(7):182\u2013186."}, {"Citation": "Wang BC, Wang LL, Yuan JF. Clinical observation on expelling turbid and removing stagnation formula in the treatment of non-alcoholic steatohepatitis. World Chin Med. 2016;11(8):1468\u20131470."}, {"Citation": "Wang YX, Zang JW, Fu ZQ, Zhang JF, Cao HY. Clinical research of fatty liver with the treatment of strengthening behevior intervention combined with Bushenyiqi. Chin J Integr Tradt West Med Liver Dis. 2016;26(2):76\u201378."}, {"Citation": "Yu S, Zhu JF, Lin Y, et al. Clinical observation of \u201cQinggan Jiangzhi decoction\u201d in treating non-alcoholic steatohepatitis with spleen-deficiency and phlegm-stasis. Shanghai J Tradit Chin Med. 2016;50(9):45\u201347."}, {"Citation": "Zhang T, Zhang RM, Kang WR, Wu JH. Yiqi Qizhu decoction in treating non-alcoholic steatohepatitis. Jiangxi J Tradit Chin Med. 2016;7(47):33\u201335."}, {"Citation": "Zhang HY, Yu X, Xing LJ. Clinical observation on the effect of Jiang Zhi granules in the treatment of non-alcoholic fatty liver disease with damp-heat symdrome. Chin J Integr Tradit West Med Liver Dis. 2016;26(7):140\u2013142."}, {"Citation": "Zhang X, Li M. Curative effect of modified wumei decoction on non-alcoholic steatohepatitis with chronic obstructive pulmonary disease. Chin J Integr Tradit West Med Liver Dis. 2016;26(1):21\u201322."}, {"Citation": "Chen SD, Yang JE, Wang HG, Lin MT, Tang JM, Liang HQ. Clinical study of Zaozhu Yinchen decoction in treating non-alcoholic fatty liver disease. Tradit Chin Med J. 2015;14(1):46\u20138, 64 (in Chinese)."}, {"Citation": "Chen YF, Chen WX, Liu Y, Zhang HY, Li Kun. Clinical study on the treatment of traditional Chinese medicine or Western medicine combined behavioral intervention on abnormal glucose metabolism in non-alcoholic fatty liver. Chin J Integr Tradit West Med Liver Dis. 2015;25(2):80\u20133 (in Chinese)."}, {"Citation": "Shan LL. Clinical study on the treatment of non-alcoholic fatty liver complicated with obesity with Quzhi Baogan formula. Asia-Pacific Tradit Med. 2015;11(22):123\u2013124."}, {"Citation": "Dong K. Analysis on the efficacy and safety of Shugan Jianpi Formula in the treatment of non-alcoholic steatohepatitis. World Latest Med Inf. 2015;15(78):163\u2013164."}, {"Citation": "Feng GF, Chen R. Clinical observation on treating non-alcoholic steatohepatitis with the Shengjiang decoction. Clin J Chin Med. 2015;7(14):14\u201316."}, {"Citation": "Huang LY, Zheng C, Zhang X, et al. The clinical effect of strengthening spleen and excerting dampness decoction in the treatment of non-alcoholic steatohepatitis. Chin J Integr Tradit West Med Liver Dis. 2015;25(5):261\u2013264."}, {"Citation": "Li XJ. Clinical study on the treatment of patients with non-alcoholic steatohepatitis with optimised scheme of traditional Chinese medicine. Contemporary Med. 2015;21(13):385 (in Chinese)."}, {"Citation": "Li Y, Li K, Shen TB. Effect of Qinghua decoction combined life-style intervening on 60 NASH patients with phlegmy syndrome. Chin J Integr Tradit West Med Liver Dis. 2015;25(1):18\u201320."}, {"Citation": "Liu FR, Guo XJ, Li JP. 34 cases of non-alcoholic steatohepatitis treated with lipid reducing and liver tonics. Shaanxi Chin Med. 2015;36(1):8\u20139."}, {"Citation": "Liu YG. Clinical study on the treatment of non-alcoholic steatohepatitis with Jiangzhi Huazhuo decoction and Bacillus licheniformis. Henan Tradit Chin Med. 2015;35(8):1833\u20131835."}, {"Citation": "Tang KB, Xia RX, Deng JH, Li LJ, Zhang Shu. The clinical effect of Jianpi Jiangzhi decoction combined with Wuling Fugan capsule in the treatment of spleen beficiency turbidity and blood stasis resistance type non-alcoholic fatty hepatitis. Progress in Modern Biomed. 2015;15(8):1495\u20137 (in Chinese)."}, {"Citation": "Wang X. Observation of the effect of treating patients with non-alcoholic steatohepatitis with an optimal Chinese medicine therapy. Contemp Med Forum. 2015;13(12):38\u201339."}, {"Citation": "Ye MQ. Evaluation of the efficacy of combined Chinese and Western medicine in the treatment of non-alcoholic steatohepatitis. J Chin Hepatol. 2015;20(6):462\u2013467."}, {"Citation": "Li JX, Wang YL, Liu M, et al. Treatment of non-alcoholic steatohepatitis by Jianpi Shugan recipe: a multi-center randomized controlled clinical trial. Chin J Integr Tradit West Med. 2014;34(1):15\u201329.", "ArticleIdList": ["24520780"]}, {"Citation": "Li SF, Mao MH, Yuan C. Observation on therapeutic effect of Xiaozhi Pinggan capsule on non-alcoholic steatohepatitis. Shaanxi J Tradit Chin Med. 2014;35(10):1379\u20131380."}, {"Citation": "Liu J, Xue JH, Wu YX, Zhong RS. Clinical study of Ruangan Jiangzhi capsule in treating non-alcoholic fatty liver disease. Jiangsu J Tradit Chin Med. 2014;46(2):31\u201332."}, {"Citation": "Yu JP, Feng LY, Chen X, Chen J. Polyene phosphatidyl choline joint fuzheng huayu capsule in treating non-alcoholic fatty hepatitis. Chin J General Prac. 2014;12(8):1325\u20131326."}, {"Citation": "Zheng H. 72 cases of non-alcoholic steatohepatitis treated with integrated traditional chinese and western medicine. Chin Med Modern Dist Educ Chin. 2014;12(16):136\u2013137."}, {"Citation": "Hou GH, Wang HL, Zhou HX, et al. Effect of Jianpi Tiaozhi Huayu recipe combined with Metformin tablet in the treatment of obesity and non-alcoholic steatohepatitis. Chin J Integr Trad West Med Dig. 2013;21(1):11\u201314."}, {"Citation": "Huang MH, Chen XR. Observation on the therapeutic effect of Zhigankang on non-alcoholic steatohepatitis. Infor Tradit Chin Med. 2013;30(2):31\u201332."}, {"Citation": "Li HS, Feng Q, Zhu DD, Ying H, Li DZ, Fu QL. Clinical observation on Qushi Huayu decoction for 82 cases of non-alcoholic steatohepatitis with phlegm\u2014stasis accumulation syndrome. Chin Arch Tradit Chin Med. 2013;31(8):1764\u20131767."}, {"Citation": "Qiu XY. 45 cases of non-alcoholic steatohepatitis treated with the combination of Shugan Huazhuo Formula and Yishanfu. Chin J Integr Tradit West Med Liver Dis. 2013;23(3):174\u2013175."}, {"Citation": "Wang JZ. Clinical effect on Xiao Zhi prescription treating 42 cases of non-alcoholic steatohepatitis. World Chin Med. 2013;8(7):752\u2013754."}, {"Citation": "Wei CS, Tang HH, Tong GD. Treatment of non-alcoholic steatohepatitis with liver de-lipidizing formula combined with polyene-phosphatidylcholine Clinical study of 36 cases of steatohepatitis. Jiangsu J Tradit Chin Med. 2013;45(7):17\u201319."}, {"Citation": "Zhan BL, Zhang L, Li Q. Observation on treating NASH with Baohe pill combined with polyene-phosphatidylcholine capsule. Clinical J of Chin Med. 2013;5(2):22\u201324."}, {"Citation": "Chen X, Wu L, Huang YR. Clinical study of Jindanwang mixture on non-alcoholic steatohepatitis. Chin J Integr Tradit West Med Liver Dis. 2012;22(2):94\u201396."}, {"Citation": "Chen ZQ, Tu YY. Curative effect analysis of Jiangzhi Baogan decoction in non-alcoholic steatohepatitis patients of phlegm-stasis syndrome. J Liaoning Univ TCM. 2012;14(1):155\u2013157."}, {"Citation": "Ling JS, Song B, Huang XH. 31 cases of non-alcoholic steatohepatitis treated with dampness, phlegm and stasis removal method. Shaanxi J Tradit Chin Med. 2012;33(9):1118\u20131120."}, {"Citation": "Lu J, Wang CB, Wang J, Shi FB, Li YP, Xie TX, Zhang LM. Effect of Chinese herbal medicine on peripheral blood T lymphocyte subsets and liver function in patients with non-alcoholic steatohepatitis. J Clin Hepatol. 2012;15(2):133\u2013134."}, {"Citation": "Pei Q, Wang XS, Wang XB, et al. Clinical study of Qinggan Huatan Huoxue recipe on the treatment of non-alcoholic steatohepatitis. Chin J Integr Tradit West Med. 2012;32(1):29\u201331.", "ArticleIdList": ["22500386"]}, {"Citation": "Qian YL, Chen WM. Clinical study on 220 cases of non-alcoholic steatohepatitis treated with \"aromatic fat elimination formula\" in various Chinese medical symptoms. Jiangsu Tradit Chin Med. 2013;44(12):19\u201320."}, {"Citation": "Wang JH. 40 cases of non-alcoholic steatohepatitis treated with blood activation and lipid-lowering formula. Chin J Integr Tradit West Med Liver Dis. 2012;22(4):246\u2013247."}, {"Citation": "Wang YP, Zheng X, Zhang ZY, et al. Clinical observation of \u201cYigan Jiedu decoction\u201d in treating non-alcoholic steatohepatitis of phlegm and blood-stasis accumulation. Shanghai J Tradit Chin Med. 2012;46(12):25\u201327."}, {"Citation": "Zhang XJ. Observations on the efficacy of liver protection and lipid-lowering formula in the treatment of non-alcoholic steatohepatitis. Prac Clinical J Integr Tradit Chin West Med. 2021;12(1):30\u201331."}, {"Citation": "Zhao WX, Liu JY, Meng XL. Effect of Huatan Xiezhuo recipe combined exercise and dietary treatment on TG/ALT/BMI levels in patients with non-alcoholic steatohepatitis. Chin J Tradit Chin Med Pharm. 2021;27(3):654\u2013656."}, {"Citation": "Gu BY, Zhang QH, Ma GJ, Zhang X, Zhang J, Zhang AN. Clinical observation on Zhigan capsule for 50 cases of non-alcoholic steatohepatitis. Guid J Tradit Chin Med Pharm. 2011;17(1):39\u201341."}, {"Citation": "Wang YX, Xu Z, Fei M. Clinical study on the treatment of fatty liver by tonifying the kidneys and benefiting the spleen. Chin J of Basic Chin Med. 2011;17(3):296\u2013297."}, {"Citation": "Zhang SJ, Q YY, Qian H, et al. Clinical study on Kangzhi decoction in treating 92 cases of non-alcoholic fatty liver disease differentiated as syndrome type of spleen as thenia as dampness heat. Chin J Integr Tradit West Med Liver Dis. 2011;21(2):71\u20133 (in Chinese)."}, {"Citation": "Zhao WX, Liu QZ, Xia JY, et al. Clinical trial of Chinese medicine for the treatment of non-alcoholic steatohepatitis. Chin J Exp Tradit Med Formulae. 2011;17(23):246\u2013249."}, {"Citation": "Li J, Wang XY. Clinical observation on the treatment of non-alcoholic steatohepatitis by combining Spleen and Liver Pill with Silymarin capsule. Chin J Inf TCM. 2010;17(1):68\u201369."}, {"Citation": "Liang DY, Ge Y, Shen CG. Clinical study on the treatment of non-alcoholic steatohepatitis with the formula of strengthening the spleen and removing turbidity. Contemp Med. 2010;16(21):19\u201321."}, {"Citation": "Lin ZR, Fan H, Deng X, Wu WK. Observation on the therapeutic effect of 57 cases of non-alcoholic steatohepatitis treated with self-made Jianpi Huatan recipe. Chin J Integr Tradit West Med Liver Dis. 2010;20(1):48\u201349."}, {"Citation": "Ma J, Sun Y, Huang RZ. Curative effect of Qinggan Xiaozhi decoction on non-alcoholic steatohepatitis. Prac Clin J Integr Tradit Chin West Med. 2010;10(2):5\u20136."}, {"Citation": "Chen HP, Yao J, Chen ZD, Gao YQ. Clinical study of Shenge decoction and dietotherapy, kinesitherapy on non-alcoholic fatty hepatitis. Chin J Integr Tradit West Med Liver Dis. 2009;19(5):273\u2013275."}, {"Citation": "Li X, Xing L, Sun LH, Wang L. Clinical observation of 38 patients with curing non-alcohol fatty Liver treated by using antilipemic and protecting liver decoction. J Liaoning Univ TCM. 2009;11(5):114\u2013115."}, {"Citation": "Wang SL. Treatment of non-alcoholic steatohepatitis with the method of tonifying the spleen, raising the yang and dipping the fire in 43 cases. Shandong J Tradit Chin Med. 2009;28(9):604\u2013605."}, {"Citation": "Zhang AJ, Lu YJ, Chen XR. Clinical observation of \u201cQinggan Huayu Decoction\u201d in treating hepatic fibrosis following non-alcoholic fatty liver diseases. Shanghai J Tradit Chin Med. 2009;43(6):33\u201335."}, {"Citation": "Zhang SJ, Chen ZX, Jiang KP, et al. The effect of QuYuHuaTanTongLuo Decoction on the non-alcoholic steatohepatitis. Complement Ther Med. 2008;16(4):192\u2013198. doi: 10.1016/j.ctim.2007.08.004.", "ArticleIdList": ["10.1016/j.ctim.2007.08.004", "18638709"]}, {"Citation": "Li XY. Treatment of 45 cases of non-alcoholic fatty hepatitis with Zhibitai capsule. Shaanxi Chin Med. 2008;29(12):1643 (in Chinese)."}, {"Citation": "Lu WL, Zhao BL. Treatment of 40 cases of non-alcoholic steatohepatitis with the method of resolving phlegm and relieving depression. TCM Res. 2008;21(6):37\u201339."}, {"Citation": "Sun LH, Chen YL, Huang XA. 31 cases of non-alcoholic steatohepatitis treated with the Pinggan Huoxue formula. Shangdong J Tradit Chin Med. 2008;27(5):297\u2013299."}, {"Citation": "Wang HB, Wei L, Jin HW, Wei ZM. Clinical observation on the treatment of non-alcoholic steatohepatitis and fibrosis with integrated traditional Chinese and western medicine. Herald of Med. 2007;26(9):1035\u20131036."}, {"Citation": "Yang HR, Yang ZY, Xiang RY, Yang SZ. Clinical study on treatment of fatty liver by Yigan Jiangzhi capsule. Chin J Integr Tradit West Med Liver Dis. 2007;17(1):56\u201357."}, {"Citation": "Chande N, Laidlaw M, Adams P, et al. Yo Jyo Hen Shi Ko (YHK) improves transaminases in non-alcoholic steatohepatitis (NASH): a randomised pilot study. Dig Dis Sci. 2006;51(7):1183\u20131189. doi: 10.1007/s10620-006-8030-y.", "ArticleIdList": ["10.1007/s10620-006-8030-y", "16944007"]}, {"Citation": "Chen L, Jiang YK, Cai YB. Effects of Resolving Phlegm Method on Fibrinolytic Status in Non-alcoholic Steatohepatitis Patients of Phlegm and Blood-stasis Syndrome. Chin J Integr Tradit West Med. 2006;26(12):1090\u20131093.", "ArticleIdList": ["17205821"]}, {"Citation": "Bai J, Chang YH, Bai YC, et al. Effect of combination traditional Chinese and Western medicine on transform in growth factor-\u03b2_1 in treatment of non-alcoholic steatohepatitis. Chin General Clin. 2005;21(8):705\u2013707."}, {"Citation": "Li YS, Hu SL. Chinese herbal medicine combined with Alto Moran for non-alcoholic steatohepatitis. Zhengjiang J Integr Tradit Chin West Med. 2005;15(10):608\u2013609."}, {"Citation": "Luo CJ, He QH, Jiang DC, Lan J. A clinical observation on NASH by treatment based on comprehensive analysing symptoms and diseases. Chin J Integr Tradit West Med Liver Dis. 2004;14(5):272\u2013274."}, {"Citation": "Professional Committee of Digestive System Diseases, Chinese Society of Integrative Medicine. Consensus opinions on diagnosis and treatment of non-alcoholic fatty liver disease with integrated traditional Chinese and western medicine. Chin J Integr Tradit West Med. 2011;31(2):155\u20138 (in Chinese).", "ArticleIdList": ["21425564"]}, {"Citation": "Professional Committee of Digestive System Diseases, Chinese Society of Integrative Medicine. Consensus opinions on diagnosis and treatment of non-alcoholic fatty liver disease with integrated traditional Chinese and western medicine. Chin J Integr Tradit West Med. 2017;25(11):805\u201311 (in Chinese)."}, {"Citation": "The Chinese National Workshop on Fatty Liver and Alcoholic Liver Disease for the Chinese Liver Disease Association the Chinese Liver Disease Association. Guidelines for management of alcoholic liver disease an updated and revised edition. Chin J Hepatol. 2010;18(3):167\u201370 (in Chinese).", "ArticleIdList": ["20698076"]}, {"Citation": "National Administration of Traditional Chinese Medicine. Diagnostic efficacy criteria for TCM diseases. 1994;56."}, {"Citation": "Zhao C, Zhou Y, Ping J, et al. Traditional Chinese medicine for treatment of liver diseases: progress, challenges and opportunities. J Integr Med. 2014;12(5):401\u2013408. doi: 10.1016/S2095-4964(14)60039-X.", "ArticleIdList": ["10.1016/S2095-4964(14)60039-X", "PMC7128864", "25292339"]}, {"Citation": "Shi T, Wu L, Ma W, et al. Non-alcoholic fatty liver disease: pathogenesis and treatment in traditional Chinese medicine and western medicine. Evidence Based Complement Altern Med. 2020;1:1.", "ArticleIdList": ["PMC6969649", "31998400"]}, {"Citation": "Ying-Rong L, Zhang MH, Jian-Guang LUO, et al. Pathogenesis of NASH and promising natural products. Chin J Nat Med. 2021;19(1):12\u201327.", "ArticleIdList": ["33516448"]}, {"Citation": "Wang T, Huang S, Wu C, Wang N, Zhang R, Wang M, Mao D. Intestinal microbiota and liver diseases: insights into therapeutic use of traditional chinese medicine. Evid Based Complement Alternat Med. 2021;22(2021):6682581. doi: 10.1155/2021/6682581.", "ArticleIdList": ["10.1155/2021/6682581", "PMC8087485", "33976705"]}, {"Citation": "Lee TY, Chang HH, Lo WC, Lin HC. Alleviation of hepatic oxidative stress by Chinese herbal medicine Yin-Chen-Hao-Tang in obese mice with steatosis. Int J Mol Med. 2010;25(6):837\u2013844. doi: 10.3892/ijmm_00000412.", "ArticleIdList": ["10.3892/ijmm_00000412", "20428786"]}, {"Citation": "Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest. 2004;114(2):147\u2013152. doi: 10.1172/JCI22422.", "ArticleIdList": ["10.1172/JCI22422", "PMC449757", "15254578"]}, {"Citation": "Belfort R, Harrison SA, Brown K, et al. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. N Engl J Med. 2006;355(22):2297\u20132307. doi: 10.1056/NEJMoa060326.", "ArticleIdList": ["10.1056/NEJMoa060326", "17135584"]}, {"Citation": "Wang YL, Liu LJ, Zhao WH, Li JX. Intervening TNF-\u03b1 via PPAR\u03b3 with gegenqinlian decoction in experimental nonalcoholic fatty liver disease. Evid Based Complement Alternat Med. 2015;2015:715638.", "ArticleIdList": ["PMC4499399", "26221176"]}, {"Citation": "Yuanyuan W, Minghua J, Lina Z, Suhua L, Jiayu Z, Yongzhi S, Chunyu C, Jian Q. Effect of a combination of calorie-restriction therapy and Lingguizhugan decoction on levels of fasting blood lipid and inflammatory cytokines in a high-fat diet induced hyperlipidemia rat model. J Tradit Chin Med. 2015;35:218\u2013221. doi: 10.1016/S0254-6272(15)30031-5.", "ArticleIdList": ["10.1016/S0254-6272(15)30031-5", "25975056"]}, {"Citation": "Li T, Han JY, Wang BB, et al. Huanglian jiedu decoction regulated and controlled differentiation of monocytes, macrophages, and foam cells: an experimental study. Zhongguo Zhong Xi Yi Jie He Zazhi. 2014;34:1096\u20131102.", "ArticleIdList": ["25335334"]}, {"Citation": "Zhang A, Sun H, Wang X. Potentiating therapeutic effects by enhancing synergism based on active constituents from traditional medicine. Phytother Res. 2014;28(4):526\u2013533. doi: 10.1002/ptr.5032.", "ArticleIdList": ["10.1002/ptr.5032", "23913598"]}, {"Citation": "Wang X, Zhang A, Wang P, et al. Metabolomics coupled with proteomics advancing drug discovery toward more agile development of targeted combination therapies. Mol Cell Proteomics. 2013;12(5):1226\u20131238. doi: 10.1074/mcp.M112.021683.", "ArticleIdList": ["10.1074/mcp.M112.021683", "PMC3650334", "23362329"]}, {"Citation": "Weiskirchen R, Mahli A, Weiskirchen S, et al. The hop constituent xanthohumol exhibits hepatoprotective effects and inhibits the activation of hepatic stellate cells at different levels. Front Physiol. 2015;6:140. doi: 10.3389/fphys.2015.00140.", "ArticleIdList": ["10.3389/fphys.2015.00140", "PMC4422013", "25999863"]}, {"Citation": "Huang L, Zhang Y, Zhang X, et al. Therapeutic potential of Pien-Tze-Huang: a review on its chemical composition, pharmacology, and clinical application. Molecules. 2019;24(18):3274. doi: 10.3390/molecules24183274.", "ArticleIdList": ["10.3390/molecules24183274", "PMC6767116", "31505740"]}, {"Citation": "Mu Y, Liu P, Du G, et al. Action mechanism of Yi Guan Jian Decoction on CCl4 induced cirrhosis in rats. J Ethnopharmacol. 2009;121(1):35\u201342. doi: 10.1016/j.jep.2008.09.032.", "ArticleIdList": ["10.1016/j.jep.2008.09.032", "18996463"]}, {"Citation": "Zhou YN, Mu YP, Fu WW, et al. Yiguanjian decoction and its ingredients inhibit angiogenesis in carbon tetrachloride-induced cirrhosis mice. BMC Complement Altern Med. 2015;15(1):1\u20139. doi: 10.1186/s12906-015-0862-6.", "ArticleIdList": ["10.1186/s12906-015-0862-6", "PMC4591631", "26427787"]}, {"Citation": "Shui S, Shen S, Huang R, et al. Metabonomic analysis of biochemical changes in the plasma and urine of carrageenan-induced rats after treatment with Yi-Guan-Jian decoction. J Chromatogr B. 2016;1033:80\u201390. doi: 10.1016/j.jchromb.2016.08.003.", "ArticleIdList": ["10.1016/j.jchromb.2016.08.003", "27525358"]}, {"Citation": "Wei D, Liao S, Wang J, et al. Cholestatic liver injury model of bile duct ligation and the protection of Huang-Lian-Jie-Du decoction by NMR metabolomic profiling. RSC Adv. 2015;5(81):66200\u201366211. doi: 10.1039/C5RA12224D.", "ArticleIdList": ["10.1039/C5RA12224D"]}, {"Citation": "Wei DD, Wang JS, Duan JA, et al. Metabolomic assessment of acute cholestatic injuries induced by thioacetamide and by bile duct ligation, and the protective effects of Huang-Lian-Jie-Du-decoction. Front Pharmacol. 2018;9:458. doi: 10.3389/fphar.2018.00458.", "ArticleIdList": ["10.3389/fphar.2018.00458", "PMC5952270", "29867467"]}, {"Citation": "Lu J, Wang JS, Kong LY. Anti-inflammatory effects of Huang-Lian-Jie-Du decoction, its two fractions and four typical compounds. J Ethnopharmacol. 2011;134(3):911\u2013918. doi: 10.1016/j.jep.2011.01.049.", "ArticleIdList": ["10.1016/j.jep.2011.01.049", "21296144"]}, {"Citation": "Li T, Han JY, Wang BB, et al. Huanglian jiedu decoction regulated and controlled differentiation of monocytes, macrophages, and foam cells: an experimental study. Chin J Integr Tradit Western Med. 2014;34(9):1096\u20131102.", "ArticleIdList": ["25335334"]}, {"Citation": "Jin J, Zhang Y, Hu WX, et al. Effects of Huanglian Jiedu Decoction on blood lipid metabolism and its related gene expressions in rats with hyperlipidemia. J Chin Integr Med. 2010;8(3):275\u2013279. doi: 10.3736/jcim20100313.", "ArticleIdList": ["10.3736/jcim20100313", "20226151"]}, {"Citation": "Yu YL, Lu SS, Yu S, et al. Huang-lian-jie-du-decoction modulates glucagon-like peptide-1 secretion in diabetic rats. J Ethnopharmacol. 2009;124(3):444\u2013449. doi: 10.1016/j.jep.2009.05.027.", "ArticleIdList": ["10.1016/j.jep.2009.05.027", "19497359"]}, {"Citation": "Park S, Hong SM, Ahn IS, et al. Huang-Lian-Jie-Du-Tang supplemented with Schisandra chinensis Baill. and Polygonatum odoratum Druce improved glucose tolerance by potentiating insulinotropic actions in islets in 90% pancreatectomised diabetic rats. Biosci Biotechnol Biochem. 2009;73(11): 2384\u20132392.", "ArticleIdList": ["19897925"]}, {"Citation": "Dang Y, Hao S, Zhou W, et al. The traditional Chinese formulae Ling-Gui-Zhu-Gan decoction alleviated non-alcoholic fatty liver disease via inhibiting PPP1R3C mediated molecules. BMC Complement Altern Med. 2019;19(1):1\u201311. doi: 10.1186/s12906-018-2424-1.", "ArticleIdList": ["10.1186/s12906-018-2424-1", "PMC6323852", "30616587"]}, {"Citation": "Cai FF, Bian YQ, Wu R, et al. Yinchenhao decoction suppresses rat liver fibrosis involved in an apoptosis regulation mechanism based on network pharmacology and transcriptomic analysis. Biomed Pharmacother. 2019;114:108863. doi: 10.1016/j.biopha.2019.108863.", "ArticleIdList": ["10.1016/j.biopha.2019.108863", "30991286"]}, {"Citation": "National Administration of Traditional Chinese Medicine of China. Catalog of antient classic traditional Chinese medicine prescriptions. 2018. http://www.satcm.gov.cn/kejisi/zhengcewenjian/2018-04-16/7107.html. Accessed 31 Sept 2022."}, {"Citation": "Ye H, Zheng C, Xu X, et al. Potential synergistic and multitarget effect of herbal pair Chuanxiong Rhizome-Paeonia Albifora Pall on osteoarthritis disease: a computational pharmacology approach. Chin J Integr Med. 2011;17(9):698\u2013703. doi: 10.1007/s11655-011-0853-5.", "ArticleIdList": ["10.1007/s11655-011-0853-5", "21910072"]}, {"Citation": "Li L, Lan X, Peng X, et al. Polysaccharide from salviae miltiorrhizae radix et rhizoma attenuates the progress of obesity-induced non-alcoholic fatty liver disease through modulating intestinal microbiota-related gut-liver axis. Int J Mol Sci. 2022;23(18):10620. doi: 10.3390/ijms231810620.", "ArticleIdList": ["10.3390/ijms231810620", "PMC9505563", "36142520"]}, {"Citation": "Biao Y, Chen J, Liu C, et al. Protective effect of danshen Zexie decoction against non-alcoholic fatty liver disease through inhibition of ROS/NLRP3/IL-1\u03b2 pathway by Nrf2 signaling activation. Front Pharm. 2022;2446:1.", "ArticleIdList": ["PMC9253674", "35800450"]}, {"Citation": "Wu L, Yan Q, Chen F, et al. Bupleuri radix extract ameliorates impaired lipid metabolism in high-fat diet-induced obese mice via gut microbia-mediated regulation of FGF21 signaling pathway. Biomed Pharmacother. 2021;135:111187. doi: 10.1016/j.biopha.2020.111187.", "ArticleIdList": ["10.1016/j.biopha.2020.111187", "33556916"]}, {"Citation": "Povsic M, Wong OY, Perry R, et al. A structured literature review of the epidemiology and disease burden of non-alcoholic steatohepatitis (NASH) Adv Ther. 2019;36(7):1574\u20131594. doi: 10.1007/s12325-019-00960-3.", "ArticleIdList": ["10.1007/s12325-019-00960-3", "PMC6824389", "31065991"]}, {"Citation": "Filozof C, Chow SC, Dimick-Santos L, et al. Clinical endpoints and adaptive clinical trials in precirrhotic non-alcoholic steatohepatitis: facilitating development approaches for an emerging epidemic. Hepatol Commun. 2017;1(7):577\u2013585. doi: 10.1002/hep4.1079.", "ArticleIdList": ["10.1002/hep4.1079", "PMC5721443", "29404480"]}, {"Citation": "Sanyal AJ, Brunt EM, Kleiner DE, et al. Endpoints and clinical trial design for non-alcoholic steatohepatitis. Hepatology. 2011;54:344\u2013353. doi: 10.1002/hep.24376.", "ArticleIdList": ["10.1002/hep.24376", "PMC4014460", "21520200"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "3", "Day": "3"}, {"Year": "2023", "Month": "4", "Day": "28"}, {"Year": "2023", "Month": "5", "Day": "20", "Hour": "9", "Minute": "43"}, {"Year": "2023", "Month": "5", "Day": "20", "Hour": "9", "Minute": "42"}, {"Year": "2023", "Month": "5", "Day": "19", "Hour": "23", "Minute": "40"}, {"Year": "2023", "Month": "5", "Day": "19"}], "PublicationStatus": "epublish", "ArticleIdList": ["37208742", "PMC10199512", "10.1186/s13020-023-00761-5", "10.1186/s13020-023-00761-5"]}}], "PubmedBookArticle": []}